Author

Stefan Bräse

Karlsruhe Institute of TechnologyORCID 0000-0003-4845-3191Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Nicole JungiD· 3 shared Andrew C.B. CatoiD· 2 shared Jutta StoberiD· 2 shared Abhilash DeoiD· 1 shared Adam SharpiD· 1 shared Alana L. WelmiD· 1 shared Amanda SwainiD· 1 shared Ana FerreiraiD· 1 shared

Activity by Year

2022-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Nicole JungORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintAug 5, 2026

The coumarin derivative X6632 is a pan-ID protein inhibitor that suppresses tumor growth by targeting cancer cells and the tumor-associated microvasculature

Lea S. Götz, Abhilash Deo, Sandra D. Scherer…·Jonathan Paul Sleeman

DOI 10.64898/2026.08.05.742008

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJul 28, 2025

Distinct 2-phenyl-imidazo pyridine derivatives drive ER degradation and selectively impair proliferation of ER+ breast cancer cells via the aryl hydrocarbon receptor

Katrin Koellisch, Christine Blattner, Stefano Motta…·Andrew C.B. Cato

The paper identifies X15695 as an AHR ligand that promotes ER degradation and inhibits ER+ breast cancer cell proliferation more effectively than fulvestrant.

1 citation

humanexperimental assay

𝕏 PostBluesky

Molecular BiologybioRxivPreprintOct 17, 2022

Targeting the BAG-1 family of co-chaperones in lethal prostate cancer.

Antje Neeb, Ines Figueiredo, Denisa Bogdan…·Adam Sharp

This study investigates Thio-2's mechanism of action in inhibiting AR signaling in CRPC, showing it acts independently of BAG-1 isoforms and with potential AR NTD binding.

DOI 10.1101/2022.10.17.512378

humanproteomics

𝕏 PostBluesky

Stefan Bräse · henhao